The Next Big Thing In Biotech: 2011 Review

Adam Feuerstein, Sr. Columnist for TheStreet, reviews the biggest biotech stories in 2011 and also looks ahead to 2012.

Fri 12/16/11 04:45 AM EST -- Adam Feuerstein & Gregg Greenberg